[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-drug] Cost effectiveness and cost benefit analysis (3)

  • From: "Kees de Joncheere" <cjo@euro.who.int>
  • Date: Fri, 1 Apr 2005 23:27:52 +0200

E-DRUG: Cost effectiveness and cost benefit analysis (3)
--------------------------------------------------------

Dear E-druggers,

See also
http://www.ispor.org/ that has an interesting set of economic guidelines used in different countries in the world.

And the very informative website of NICE in the UK at http://www.nice.org.uk/

best regards,

Kees de Joncheere
Regional adviser Health technology and Pharmaceuticals
WHO Regional office for Europe
8 Scherfigsvej, 2100 Copenhagen, Denmark
tel 45-39171432
fax 45-39171855
email cjo@euro.who.int
http://www.euro.who.int/pharmaceuticals